Intraosseous Pressure Monitoring in Intensive Care Unit Patients
NCT ID: NCT02059928
Last Updated: 2018-07-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2013-12-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Invasive CVP Method to Standard CVP Method
NCT03705299
Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care
NCT01495429
Central Venous Catheter Placement With Thoracic Ultrasound and Intracavity ECG Positioning
NCT07291869
Central Venous Pressure Versus Inferior Vena Cava Distensibility Index in Assessing Fluid Responsiveness in Septic Shocked Patients
NCT07279064
Central Venous Pressure and Right Atrial Pressure Measurements in Supine, Semi-recumbent and Trendelenburg Position
NCT06705374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intraosseous device placement
Intraosseous device
Intraosseous Device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraosseous Device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to the surgical intensive care units
* Current central pressure monitoring through a central line
* Patient currently intubated and sedated
* Informed consent obtained from family member
* English speaking patient
Exclusion Criteria
* Known osteoporosis, avascular necrosis, or other bone pathology affecting bone healing.
* Fracture or other significant injury to the tibia or humerus or surrounding musculature/tissue.
* Inability to landmark IO placement due to excessive tissue over placement location.
* Anticipated surgery within 12 hours of time of consent
* Current infection at the placement site.
* Previous, significant orthopedic procedure at the site
* Pregnant or has the potential for being pregnant
* Prisoner of the state
* Minor (\< 18 years old)
* Inability to obtain informed consent from family member
* Non-English speaking patient
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vidacare Corporation
INDUSTRY
HealthPartners Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ralph J Frascone, MD
Role: PRINCIPAL_INVESTIGATOR
Regions Hospital
Josh Salzman, MA
Role: STUDY_DIRECTOR
Regions Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Regions Hospital
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.